The World Health Organization continues to recommend AstraZeneca for vaccination against the background of mass refusals from its use, as the benefits of the drug outweigh the risks, according to a statement ahead of the final WHO assessment of the safety of the vaccine.
“The WHO currently believes that the benefits of the AstraZeneca vaccine outweigh the risks and recommends continued vaccination,” the statement said.
The organization stressed that venous thromboembolism, detected in some patients after the AstraZeneca vaccination, is the third most common cardiovascular disease globally. And so far, there are no clear indications of a direct link between the disease and the vaccine.
WHO is in constant contact with the European Medicines Agency and regulatory authorities worldwide for the latest information on the safety of the drug.
The WHO Global Advisory Committee on Vaccine Safety is expected to announce its decision on the safety of AstraZeneca on Thursday, March 18.